Skip to main content
main-content

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editors' pick

17-09-2018 | Rheumatoid arthritis | Highlight | News

No increased risk for CVD events with tocilizumab over other RA biologic DMARDs

Tocilizumab has a cardiovascular disease risk comparable with that of etanercept and other biologic DMARDs in individuals with rheumatoid arthritis, according to findings from a large, retrospective cohort study using real-world data.

07-09-2018 | Treatment | Feature | Article

At a glance: Common scores used in rheumatology

A quick-reference guide to the scores that are commonly used in clinical trials and daily rheumatology practice.

31-07-2018 | Pain disorders | View from the clinic | Article

A multidisciplinary approach to managing chronic pain in children

Editorial board member Sangeeta Sule discusses the challenges faced when managing chronic pain in children and adolescents.

Latest from across the site

19-09-2018 | Osteoarthritis | News

Extended-release triamcinolone acetonide viable for osteoarthritis patients with type 2 diabetes

Triamcinolone acetonide extended-release may be a good option for the treatment of knee osteoarthritis in patients with comorbid type 2 diabetes, suggest phase II study findings.

Source:

Rheumatology 2018; doi:10.1093/rheumatology/key265

17-09-2018 | Rheumatoid arthritis | Highlight | News

No increased risk for CVD events with tocilizumab over other RA biologic DMARDs

Tocilizumab has a cardiovascular disease risk comparable with that of etanercept and other biologic DMARDs in individuals with rheumatoid arthritis, according to findings from a large, retrospective cohort study using real-world data.

Source:

Arthritis Care Res 2018; doi:10.1002/acr.23737

14-09-2018 | Rheumatoid arthritis | News

Early RA disease activity lower with methotrexate combination than methotrexate alone

Methotrexate–hydroxychloroquine combination therapy is associated with lower disease activity than methotrexate alone in early rheumatoid arthritis, according to a head-to-head comparison published in Rheumatology.

Source:

Rheumatology 2018; doi:10.1093/rheumatology/key275

12-09-2018 | Sjögren’s syndrome | News

News in brief

Primary Sjögren’s syndrome linked to subclinical CVD

Patients with primary Sjögren’s syndrome may have an elevated risk for subclinical cardiovascular disease, researchers report.

11-09-2018 | Spondyloarthropathies | News

Bone manifestations of PsA, nonradiographic axSpA characterized

Two studies published in Arthritis Research & Therapy describe the impact of psoriatic arthritis and nonradiographic axial spondyloarthritis on bone structure.

Source:

Arthritis Res Ther 2018; 20: 202, 203

10-09-2018 | Osteoarthritis | News

Home exercise targeting multiple muscles may be beneficial for early OA patients

A home-based exercise intervention aiming to strengthen multiple muscles improves pain and physical function among patients with preradiographic knee osteoarthritis, Japanese study results suggest.

Source:

Clin Rheumatol 2018; doi:10.1007/s10067-018-4263-3

Meet our Editorial Board

New Content Item Meet our Advisory Board

image credits